# Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006

> **NCT02008513** · PHASE2 · TERMINATED · sponsor: **Affiris AG** · enrollment: 194 (actual)

## Conditions studied

- Alzheimer´s Disease

## Interventions

- **BIOLOGICAL:** AFFITOPE® AD02
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT02008513
- **Lead sponsor:** Affiris AG
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-06
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 194 (ACTUAL)
- **Why stopped:** Study AFF006A was early terminated by the sponsor based on the results of study AFF006.
- **Last updated:** 2015-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02008513

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02008513, "Follow-up Study to Assess Safety and Clinical Activity of Continued AFFITOPE® AD02 Vaccinations of Patients Who Participated in AFF006". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02008513. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*